General Cannabis (OTCMKTS:CANN) and IM Cannabis (NASDAQ:IMCC) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
Institutional and Insider Ownership
13.7% of IM Cannabis shares are owned by institutional investors. 38.0% of General Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This is a breakdown of recent recommendations for General Cannabis and IM Cannabis, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
IM Cannabis has a consensus target price of $8.75, suggesting a potential upside of 201.83%. Given IM Cannabis’ higher probable upside, analysts plainly believe IM Cannabis is more favorable than General Cannabis.
Valuation and Earnings
This table compares General Cannabis and IM Cannabis’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|General Cannabis||$7.12 million||3.33||-$7.68 million||N/A||N/A|
|IM Cannabis||$11.86 million||16.42||-$21.42 million||($0.55)||-5.27|
General Cannabis has higher earnings, but lower revenue than IM Cannabis.
This table compares General Cannabis and IM Cannabis’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
IM Cannabis beats General Cannabis on 8 of the 10 factors compared between the two stocks.
General Cannabis Company Profile
General Cannabis Corp. is a holding company, which is engaged in the provision of lease growing space and related facilities to licensed marijuana business operators. It operates through the following segments: Security, Operations, Consumer Goods, and Investments. The Security segment provides advanced security, including on-site professionals, video surveillance and cash transport, to licensed cannabis cultivators and retail shops. The Operations segment offers consulting services to the cannabis industry that include obtaining licenses, compliance, cultivation, retail operations, logistical support, facility design and building services, and expansion of existing operations. The Consumer Goods segment includes pursuing relationships with non-cannabis national and regional apparel retailers and distributors, as well as expanding product line nationwide within the cannabis industry. The Investments segment includes expanding portfolio of loans, potentially launching a loan origination and servicing business, and investing in high-growth potential companies within the cannabis industry. The company was founded on November 12, 1987 and is headquartered in Denver, CO.
IM Cannabis Company Profile
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Receive News & Ratings for General Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for General Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.